Pillar Guide
GLP-1 Side Effects & Safety
Honest, sourced explanations of GLP-1 side effects, safety data, contraindications, and how to manage symptoms — written for patients, citing FDA and peer-reviewed research.
Every guide in this pillar is cited to primary FDA, trial, and peer-reviewed sources. See our methodology and the full central citation registry.
Start here
Guides in this pillar
Compounded Semaglutide: Is It Safe? What to Know in 2026
Honest, sourced guide to compounded semaglutide safety — FDA stance, 503A vs 503B pharmacies, what to look for in a provider, and red flags that should make you walk away.
Updated April 2026
Semaglutide Side Effects: Complete Guide to Managing Symptoms
Comprehensive, sourced guide to semaglutide side effects — nausea, constipation, fatigue, gallbladder, pancreatitis — with practical management strategies and red flags.
Updated April 2026
What Happens When You Stop Taking Ozempic? The Rebound Effect
The clinical evidence on weight regain after stopping semaglutide, why it happens, and realistic strategies for maintaining weight loss when you come off the drug.
Updated April 2026
Ozempic and Gallbladder Issues: What the Research Actually Shows
A clear-eyed look at the elevated risk of gallbladder disease on GLP-1 drugs — what the JAMA meta-analysis found, why it happens, and who's at higher risk.
Updated April 2026
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Get the Free GLP-1 Starter Guide
Plus weekly price alerts and new provider reviews.